AU2001295507A1 - Novel compounds inhibiting factor Xa activity - Google Patents

Novel compounds inhibiting factor Xa activity

Info

Publication number
AU2001295507A1
AU2001295507A1 AU2001295507A AU2001295507A AU2001295507A1 AU 2001295507 A1 AU2001295507 A1 AU 2001295507A1 AU 2001295507 A AU2001295507 A AU 2001295507A AU 2001295507 A AU2001295507 A AU 2001295507A AU 2001295507 A1 AU2001295507 A1 AU 2001295507A1
Authority
AU
Australia
Prior art keywords
activity
novel compounds
inhibiting factor
compounds inhibiting
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001295507A
Other versions
AU2001295507B2 (en
Inventor
Michael W. Cappi
Robert Eckl
Thilo Fuchs
Silke Schabbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morphochem AG fuer Kombinatorische Chemie
Original Assignee
Morphochem AG fuer Kombinatorische Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10041402A external-priority patent/DE10041402A1/en
Application filed by Morphochem AG fuer Kombinatorische Chemie filed Critical Morphochem AG fuer Kombinatorische Chemie
Publication of AU2001295507A1 publication Critical patent/AU2001295507A1/en
Application granted granted Critical
Publication of AU2001295507B2 publication Critical patent/AU2001295507B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

AU2001295507A 1999-08-23 2001-08-23 Novel compounds inhibiting factor Xa activity Expired - Fee Related AU2001295507B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19939910 1999-08-23
DE10041402 2000-08-23
DE10041402A DE10041402A1 (en) 2000-08-23 2000-08-23 Novel compounds that inhibit factor Xa activity
PCT/EP2001/009753 WO2002016312A2 (en) 2000-08-23 2001-08-23 Novel compounds inhibiting factor xa activity

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU65729/00A Division AU767333B2 (en) 1999-08-23 2000-08-23 Compounds that inhibit tryptase activity

Publications (2)

Publication Number Publication Date
AU2001295507A1 true AU2001295507A1 (en) 2002-05-30
AU2001295507B2 AU2001295507B2 (en) 2007-07-19

Family

ID=7653525

Family Applications (2)

Application Number Title Priority Date Filing Date
AU9550701A Pending AU9550701A (en) 2000-08-23 2001-08-23 Novel compounds inhibiting factor xa activity
AU2001295507A Expired - Fee Related AU2001295507B2 (en) 1999-08-23 2001-08-23 Novel compounds inhibiting factor Xa activity

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU9550701A Pending AU9550701A (en) 2000-08-23 2001-08-23 Novel compounds inhibiting factor xa activity

Country Status (17)

Country Link
US (1) US6794507B2 (en)
EP (1) EP1311473A2 (en)
JP (1) JP2004534717A (en)
KR (1) KR20040007388A (en)
CN (1) CN1332939C (en)
AU (2) AU9550701A (en)
BR (1) BR0113389A (en)
CA (1) CA2418283A1 (en)
CZ (1) CZ2003453A3 (en)
DE (1) DE10041402A1 (en)
HK (1) HK1052170A1 (en)
HU (1) HUP0301670A2 (en)
IL (1) IL154319A0 (en)
NZ (1) NZ524262A (en)
PL (1) PL365925A1 (en)
WO (1) WO2002016312A2 (en)
ZA (1) ZA200300998B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19939910A1 (en) * 1999-08-23 2001-03-01 Morphochem Ag New compounds that inhibit tryptase activity
CA2437114A1 (en) * 2001-02-23 2002-09-06 Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie Diamides which inhibit tryptase and factor xa activity
ATE384713T1 (en) 2001-07-26 2008-02-15 Lilly Co Eli 1-GLYCINYL-4-(1-METHYLPIPERIDINE-4-YL)PIPERAZINE AND -PIPERIDINE AS FACTOR XA ANTAGONISTS
KR20040096541A (en) * 2002-01-31 2004-11-16 모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 COMPOUNDS THAT INHIBIT FACTOR Xa ACTIVITY
DE10300049A1 (en) * 2003-01-03 2004-07-15 Morphochem AG Aktiengesellschaft für kombinatorische Chemie New compounds that inhibit factor VIIa
DE10204072A1 (en) * 2002-01-31 2003-08-14 Morphochem Ag Komb Chemie New compounds that inhibit factor Xa activity
ES2538469T3 (en) 2003-06-05 2015-06-22 Genentech, Inc. Combination therapy for B cell disorders
AU2006318539B2 (en) 2005-11-23 2012-09-13 Genentech, Inc. Methods and compositions related to B cell assays
US7615556B2 (en) * 2006-01-27 2009-11-10 Bristol-Myers Squibb Company Piperazinyl derivatives as modulators of chemokine receptor activity
US7601844B2 (en) * 2006-01-27 2009-10-13 Bristol-Myers Squibb Company Piperidinyl derivatives as modulators of chemokine receptor activity
EP2200631A1 (en) 2007-10-16 2010-06-30 Zymogenetics, Inc. Combination of blys inhibition and anti-cd 20 agents for treatment of autoimmune disease
EP2283355A2 (en) 2008-04-25 2011-02-16 Zymogenetics, Inc. Levels of bcma protein expression on b cells and use in diagnostic methods
US8003335B2 (en) 2008-04-30 2011-08-23 Universite Paris-SUD11 Levels of APRIL in serum and use in diagnostic methods
CA2720651C (en) 2008-05-01 2020-03-10 Zymogenetics, Inc. Levels of blys/april heterotrimers in serum and use in diagnostic methods
TWI433838B (en) 2008-06-25 2014-04-11 必治妥美雅史谷比公司 Piperidinyl derivative as a modulator of chemokine receptor activity
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
CN107385034B (en) 2009-09-03 2021-08-17 弗·哈夫曼-拉罗切有限公司 Methods for treating, diagnosing and monitoring rheumatoid arthritis
US8642622B2 (en) 2010-06-16 2014-02-04 Bristol-Myers Squibb Company Piperidinyl compound as a modulator of chemokine receptor activity
WO2013110354A1 (en) 2012-01-25 2013-08-01 Université Catholique de Louvain Compositions and methods for cell transplantation
EP2680884B1 (en) 2011-02-28 2018-01-17 F. Hoffmann-La Roche AG Biological markers and methods for predicting response to b-cell antagonists
EP3078378B1 (en) 2015-04-08 2020-06-24 Vaiomer Use of factor xa inhibitors for regulating glycemia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19653036A1 (en) * 1996-12-19 1998-06-25 Merck Patent Gmbh Cyclopeptide derivatives
IL134394A0 (en) 1997-08-27 2001-04-30 Kissei Pharmaceutical 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both
ATE243192T1 (en) 1997-12-04 2003-07-15 Hoffmann La Roche N-(4-CARBAMIMIDO-PHENYL)-GLYCINAMIDE DERIVATIVES
DE19939910A1 (en) 1999-08-23 2001-03-01 Morphochem Ag New compounds that inhibit tryptase activity

Similar Documents

Publication Publication Date Title
AU1278701A (en) Novel compounds
AU5546000A (en) Compounds
AU2001295507A1 (en) Novel compounds inhibiting factor Xa activity
AU5043500A (en) Antibacterial compounds
AU9550701A (en) Novel compounds inhibiting factor xa activity
AUPP999799A0 (en) New compound
AU2408300A (en) Novel compounds
AU1746401A (en) Compounds
AU6032100A (en) New compounds
AUPQ441499A0 (en) Novel compound
AU3997700A (en) Anti-first-pass effect compounds
PL350941A1 (en) Pyrazole-3-on-derivative as factor xa inhibitors
AU4132200A (en) Novel compounds
AUPP921299A0 (en) New heterocyclic compounds
AU2109700A (en) Novel compounds
AU5787901A (en) Compound
AU4103300A (en) Heterocyclic compounds having antitumor activity
AU2288900A (en) Novel compounds
AU5119400A (en) Compounds
AU7784700A (en) Novel compounds
AU1385701A (en) Novel compounds
AU4156800A (en) Novel compounds
AU2668000A (en) Bis-styrylbiphenyl compounds
AU6168900A (en) Compounds
AUPQ357699A0 (en) New compound WF217